Related Experiment Video
Updated: Jun 28, 2026
08:17
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
Normal tissue toxicity after small field hypofractionated stereotactic body radiation
Michael T Milano1, Louis S Constine, Paul Okunieff
1Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY 14642, USA. mtmilano@yahoo.com
Radiation Oncology (London, England)
|November 4, 2008
Summary
Stereotactic body radiation therapy (SBRT) improves tumor control and minimizes toxicity by enhancing targeting accuracy. Further research is needed to optimize dose-volume metrics for this advanced radiation oncology technique.
Area of Science:
- Radiation Oncology
- Medical Physics
Background:
- Stereotactic body radiation therapy (SBRT) is an advanced radiation oncology technique.
- It utilizes a precise 3D coordinate system for improved targeting accuracy.
- This precision allows for dose escalation and sparing of normal tissues.
Purpose of the Study:
- To review the fundamental principles of SBRT.
- To discuss the radiobiology of hypofractionated radiation.
- To analyze clinical outcomes and late toxicity of SBRT from published trials.
Main Methods:
- Literature review of published clinical trials on SBRT.
- Analysis of SBRT principles and radiobiology.
- Focus on late toxicity data.
Main Results:
- SBRT enables precise radiation delivery, minimizing normal tissue exposure.
- Clinical data suggests SBRT is generally safe.
- Published trials show promising outcomes for tumor control.
Conclusions:
- SBRT offers a balance between minimizing toxicity and maximizing tumor control.
- Further investigation into optimal dose-volume metrics is required.
- SBRT represents a significant advancement in radiation oncology.
